Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for PsychosisCassandra M.J. WannanBarnaby Nelsonet al.2024Schizophrenia Bulletin
Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratingsZarina R. BilgramiCansu Saracet al.2022Schizophrenia Research
Language as a biomarker for psychosis: A natural language processing approachCheryl M. CorcoranVijay A. Mittalet al.2020Schizophrenia Research